General Thyroid Cancer

Pass it On: It’s National Thyroid Awareness Month (09-8-2017)

The thyroid gland is a butterfly-shaped organ that is below the Adam’s apple in the front part of the neck. It produces, stores, and releases hormones that regulate vital body functions. Thyroid cancer happens when cells in the thyroid grow out of control.... Continue Reading

Complications Decrease with Surgeon Experience in Thyroidectomy (04-6-2016)

Among patients undergoing the surgical removal of their thyroid, complications associated with the procedure are drastically reduced if surgeons perform a larger number of the surgeries per year. These results were recently published in the Annals of... Continue Reading

Nexavar Approved for Metastatic Differentiated Thyroid Cancer (12-9-2013)

The U.S. Food and Drug Administration (FDA) has approved Nexavar® (sorafenib) for the treatment of metastatic differentiated thyroid cancer. Differentiated thyroid cancer is the most common type of thyroid cancer and can often be cured with surgery and... Continue Reading

Mutations Linked to Drug Response in Medullary Thyroid Cancer (11-15-2013)

Metastatic medullary thyroid cancers with certain genetic mutations respond better to treatment with Cometriq™ (cabozantinib) than tumors without those mutations, according to the results of a study presented at the 83rd Annual Meeting of the American... Continue Reading

TSH Suppression after Thyroidectomy May Not Be Beneficial (11-4-2013)

Suppression of thyroid-stimulating hormone (TSH) after thyroidectomy for low-risk cancer does not appear to reduce the risk of cancer recurrence and may even increase the risk of osteoporosis in women, according to the results of a study presented at... Continue Reading

Thyroid Ultrasound May Cut Biopsy Rate (09-13-2013)

Thyroid ultrasound may help identify certain characteristics of thyroid nodules that can predict the likelihood of cancer—and subsequently help determine whether biopsy is necessary, according to the results of a study published in the Journal of the... Continue Reading

BRAF V600E mutation Increases Death Risk in Papillary Thyroid Cancer (06-5-2013)

The presence of the BRAF V600E mutation is significantly associated with increased cancer-related death among patients with papillary thyroid cancer, according to the results of a study published in the Journal of the American Medical Association. The... Continue Reading

Selumetinib May Reverse Radioiodine Resistance in Advance Thyroid Cancer (03-28-2013)

The experimental drug selumetinib (AZD6244) may help some patients with advanced thyroid cancer overcome resistance to radioiodine, which is the most effective treatment for the disease, according to the results of a study published in the New England... Continue Reading

Targeted Drug Caprelsa Slows Thyroid Cancer (08-30-2012)

The targeted drug Caprelsa® (vandetanib) delays progression in advanced differentiated thyroid cancer, according to the results of a study published in The Lancet Oncology. The thyroid is a gland in the throat that produces hormones mostly related to... Continue Reading

Gene Expression Test Identifies Low-Risk Thyroid Nodules (06-28-2012)

A new test measures gene expression in thyroid nodules with inconclusive biopsy results and helps identify low-risk nodules, thereby preventing unnecessary surgeries, according to the results of a study published early online in the New England Journal... Continue Reading

Next Page »